← Eichor
Study identifier: NCT06070454 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions

Condition: Vaginitis · Vulvar Diseases  ·  Sponsor: University of Virginia

PhaseNA
Planned participants91
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Primary: * To measure the rate of perioperative vulvovaginitis in a population of patients in central VA with non-malignant vulvar disease who require surgical excision * To correlate the rate of vulvovaginitis with rate of wound cellulitis and incisional breakdown in patients undergoing SPV/WLE for vulvar disease We will use a vulvovaginal swab to test for the most common causes of vulvovaginitis - bacterial vaginosis (BV), trichomonas, and candida. The swab will be collected preoperatively on day of surgery. The outcome will be evaluated by phone call to patient at 1 week after surgery and physical exam at the postoperative visit between 4-6 weeks.

This description comes directly from the study's public registry record.

Talk to the study team

Amanda Urban  ·  434.409.3100  ·  AJR5Y@uvahealth.org

Always discuss trial participation with your own doctor first.

Locations (1)

University of VirginiaCharlottesville, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06070454